Stocks · News reference

8-K filing — EXELIXIS, INC. (EXEL)

Aug 31, 2026, 8:18 PMSEC EDGAR

Filed: 2026-08-31 AccNo: 0000939767-26-000104 Size: 272 KB Item 8.01: Other Events

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: edgar
Observed: Aug 31, 2026, 8:18 PM
Checked: Aug 31, 2026, 8:18 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 31, 2026, 6:48 PMBenzinga Newsdesk
Exelixis Announces Appellate Court Affirms Key Part Of 2024 Judgement Of U.S. District Court In Favor Of Co. Against MSN Laboratories; Appellate Court Upholds District Court Decision That Three Patents Are Not Invalid Covering Crystalline Malate Salt Of Cabozantinib
EXEL
BenzingaAug 19, 2026, 10:32 AMBenzinga Newsdesk
BMO Capital Initiates Coverage On Exelixis with Market Perform Rating, Announces Price Target of $54
BMO Capital analyst David Lebowitz initiates coverage on Exelixis (NASDAQ:EXEL) with a Market Perform rating and announces Price Target of $54.
EXEL
BenzingaAug 6, 2026, 4:00 PMBenzinga Newsdesk
Truist Securities Maintains Hold on Exelixis, Lowers Price Target to $52
Truist Securities analyst Gregory Renza maintains Exelixis (NASDAQ:EXEL) with a Hold and lowers the price target from $56 to $52.
EXEL